User's guide for CCT2WA (converting CCT's to work-addressable file)

The CCT2WA program, developed to convert the shuttle post-flight computer compatible tape data to a word addressable mass storage file, is described. The use of utility processors that can be used to copy word addressable files from mass storage to mass storage is also described

Genetic Variations Strongly Influence Phenotypic Outcome in the Mouse Retina

Variation in genetic background can significantly influence the phenotypic outcome of both disease and non-disease associated traits. Additionally, differences in temporal and strain specific gene expression can also contribute to phenotypes in the mammalian retina. This is the first report of microarray based cross-strain analysis of gene expression in the retina investigating genetic background effects. Microarray analyses were performed on retinas from the following mouse strains: C57BL6/J, AKR/J, CAST/EiJ, and NOD.NON-H2-nb1 at embryonic day 18.5 (E18.5) and postnatal day 30.5 (P30.5). Over 3000 differentially expressed genes were identified between strains and developmental stages. Differential gene expression was confirmed by qRT-PCR, Western blot, and immunohistochemistry. Three major gene networks were identified that function to regulate retinal or photoreceptor development, visual perception, cellular transport, and signal transduction. Many of the genes in these networks are implicated in retinal diseases such as bradyopsia, night-blindness, and cone-rod dystrophy. Our analysis revealed strain specific variations in cone photoreceptor cell patterning and retinal function. This study highlights the substantial impact of genetic background on both development and function of the retina and the level of gene expression differences tolerated for normal retinal function. These strain specific genetic variations may also be present in other tissues. In addition, this study will provide valuable insight for the development of more accurate models for human retinal diseases

A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment

This paper is a personal account on the discovery and characterization of the 5-HT2C receptor (first known as the 5- HT1C receptor) over 30 years ago and how it translated into a number of unsuspected features for a G protein-coupled receptor (GPCR) and a diversity of clinical applications. The 5-HT2C receptor is one of the most intriguing members of the GPCR superfamily. Initially referred to as 5-HT1CR, the 5-HT2CR was discovered while studying the pharmacological features and the distribution of [3H]mesulergine-labelled sites, primarily in the brain using radioligand binding and slice autoradiography. Mesulergine (SDZ CU-085), was, at the time, best defined as a ligand with serotonergic and dopaminergic properties. Autoradiographic studies showed remarkably strong [3H]mesulergine-labelling to the rat choroid plexus. [3H]mesulergine-labelled sites had pharmacological properties different from, at the time, known or purported 5-HT receptors. In spite of similarities with 5-HT2 binding, the new binding site was called 5-HT1C because of its very high affinity for 5-HT itself. Within the following 10 years, the 5-HT1CR (later named 5- HT2C) was extensively characterised pharmacologically, anatomically and functionally: it was one of the first 5-HT receptors to be sequenced and cloned. The 5-HT2CR is a GPCR, with a very complex gene structure. It constitutes a rarity in theGPCR family: many 5-HT2CR variants exist, especially in humans, due to RNA editing, in addition to a few 5-HT2CR splice variants. Intense research led to therapeutically active 5-HT2C receptor ligands, both antagonists (or inverse agonists) and agonists: keeping in mind that a number of antidepressants and antipsychotics are 5- HT2CR antagonists/inverse agonists. Agomelatine, a 5-HT2CR antagonist is registered for the treatment of major depression. The agonist Lorcaserin is registered for the treatment of aspects of obesity and has further potential in addiction, especially nicotine/ smoking. There is good evidence that the 5-HT2CR is involved in spinal cord injury-induced spasms of the lower limbs, which can be treated with 5-HT2CR antagonists/inverse agonists such as cyproheptadine or SB206553. The 5-HT2CR may play a role in schizophrenia and epilepsy. Vabicaserin, a 5-HT2CR agonist has been in development for the treatment of schizophrenia and obesity, but was stopped. As is common, there is potential for further indications for 5-HT2CR ligands, as suggested by a number of preclinical and/or genome-wide association studies (GWAS) on depression, suicide, sexual dysfunction, addictions and obesity. The 5-HT2CR is clearly affected by a number of established antidepressants/antipsychotics and may be one of the culprits in antipsychotic-induced weight gain

The Transformation from Traditional Nonprofit Organizations to Social Enterprises: An Institutional Entrepreneurship Perspective

The development of commercial revenue streams allows traditional nonprofit organizations to increase financial certainty in response to the reduction of traditional funding sources and increased competition. In order to capture commercial revenue-generating opportunities, traditional nonprofit organizations need to deliberately transform themselves into social enterprises. Through the theoretical lens of institutional entrepreneurship, we explore the institutional work that supports this transformation by analyzing field interviews with 64 institutional entrepreneurs from UK-based social enterprises. We find that the route to incorporate commercial processes and convert traditional nonprofit organizations into social enterprises requires six distinct kinds of institutional work at three different domains; these are—“engaging commercial revenue strategies”, “creating a professionalized organizational form”, and “legitimating a socio-commercial business model”. In elaborating on social entrepreneurship research and practice, we offer a comprehensive framework delineating the key practices contributing to the transformation from traditional nonprofit organizations to social enterprises. This extends our understanding of the ex-ante strategy of incorporating commercial processes within social organizations. Furthermore, the identification of these practices also offers an important tool for scholars in this field to examine the connection (or disconnection) of each practice with different ethical concerns of social entrepreneurship in greater depth.British Academ

EXPERIMENTAL-DETERMINATION OF MN-MG MIXING PROPERTIES IN GARNET, OLIVINE AND OXIDE

We have measured the mixing properties of Mn-Mg olivine and Mn-Mg garnet at 1300° C from a combination of interphase partitioning experiments involving these phases, Pt-Mn alloys and Mn-Mg oxide solid solutions. Activity coefficients of Mn dilute in Pt-Mn alloys at 1300° C/1 atm were measured by equilibrating the alloy with MnO at known fO2. Assuming that the log fO2 of the Mn-MnO equilibrium under these conditions is-17.80 (Robie et al. 1978), we obtain for γMn: logγMn = -5.25 + 3.67 XMn + 11.41X2Mn Mixing properties of (Mn,Mg)O were determined by reversing the Mn contents of the alloys in equilibrium with oxide at known fO2. Additional constraints were obtained by measuring the maximum extent of immiscibility in (Mn,Mg)O at 800 and 750° C. The data are adequately described by an asymmetric (Mn,Mg)O solution with the following upper and lower limits on nonideality: (a) WMn = 19.9kj/Mol; WMg = 13.7kj/Mol; (b) WMn = 19.9kj/Mol; WMg = 8.2kj/Mol; Olivine-oxide partitioning was tightly bracketed at 1300° C and oxide properties used to obtain activity-composition relations for Mn-Mg olivine. Despite strong M2 ordering of Mn in olivine, the macroscopic properties are adequately described by a symmetric model with: Wol = 5.5 ± 2.5 kj/mol (1-site basis) Using these values for olivine, garnet-olivine partitioning at 27 kbar/1300° C leads to an Mn-Mg interaction parameter in garnet given by: Wgt = 1.5 ± 2.5kJ/mol (1-site basis) Garnet-olivine partitioning at 9 kbar/1000° C is consistent with the same extent of garnet nonideality and the apparent absence of excess volume on the pyrope-spessartine join indicates that any pressure-dependence of WGt must be small. If olivine and garnet properties are both treated as unknown and the garnet-olivine partitioning data alone used to derive WOl and WGt, by multiple linear regression, best-fit values of 6.16 and 1.44 kJ/mol. are obtained. These are in excellent agreement with the values derived from metal-oxide, oxide-olivine and olivine-garnet equilibria. © 1994 Springer-Verlag